Name: Corcept Therapeutics Incorporated (CORT) Financial Statements
Creator: FinSpry

Corcept Therapeutics Incorporated Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scale:

Scroll to see more

Corcept Therapeutics Incorporated income statement - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018
Revenue & Gross Profit
Revenue	675.04	482.38	401.86	365.98	353.87	306.49	251.25
Cost of Revenue	10.88	6.48	5.39	5.28	5.58	5.50	5.22
Gross Profit	664.16	475.89	396.47	360.70	348.29	300.98	246.03
Operating Expenses
Research & Development	246.89	184.35	130.99	113.86	114.76	89.02	75.25
Selling, General & Administrative	280.32	184.26	152.85	122.36	105.33	100.36	81.29
Operating Expenses	527.21	368.61	283.84	236.22	220.09	189.38	156.54
Operating Income	136.95	107.28	112.63	124.48	128.20	111.61	89.50
Other Income/Expense
Interest Income	24.54	17.28	3.56	0.53	3.40	0.00	2.66
Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Income/Expense	24.54	-17.28	-3.56	-31.38	-26.49	-28.06	0.00
Income
Income Before Tax	161.49	124.56	116.19	125.01	131.60	116.68	92.15
Income Tax Expense	20.28	18.42	14.77	12.49	25.59	22.50	16.74
Net Income	141.21	106.14	101.42	112.51	106.01	94.18	75.41
Net Income - Continuous Operations	139.73	106.14	101.42	112.51	0.00	0.00	0.00
Net Income - Discontinued Operations	0.00	0.00	0.00	0.00	0.00	0.00	0.00
EBITDA	137.75	126.92	116.08	125.96	128.73	118.85	89.73
EBIT	136.95	124.56	112.63	124.48	128.20	116.68	89.50
Depreciation & Amortization	0.80	1.04	3.45	1.48	0.53	0.00	0.00
Earnings Per Share
Basic EPS	1.00	1.00	1.00	1.00	1.00	1.00	1.00
Diluted EPS	1.00	1.00	1.00	1.00	1.00	1.00	1.00
Basic Shares Outstanding	103.23	103.56	106.79	115.65	115.41	114.35	115.34
Diluted Shares Outstanding	113.48	111.74	115.97	125.96	124.19	122.57	126.69